Prostaglandin E2-bisphosphonate conjugates: potential agents for treatment of osteoporosis.
L Gil, Y Han, E E Opas, G A Rodan, R Ruel, J G Seedor, P C Tyler, R N Young
Index: Bioorg. Med. Chem. 7(5) , 901-19, (1999)
Full Text: HTML
Abstract
Conjugates of bisphosphonates (potential bone resorption inhibitors) and prostaglandin E2 (a bone formation enhancer) were prepared and evaluated for their ability to bind to bone and to liberate, enzymatically, free PGE2. The conjugate 3, an amide at C-1 of PGE2 proved to be too stable in vivo while conjugate 6, a thioester, was too labile. Several PGE2, C-15 ester-linked conjugates (18, 23, 24 and 31) were prepared and conjugate 23 was found to bind effectively to bone in vitro and in vivo and to liberate PGE2 at an acceptable rate. A 4-week study in a rat model of osteoporosis showed that 23 was better tolerated and more effective as a bone growth stimulant than daily maximum tolerated doses of free PGE2.
Related Compounds
Related Articles:
Electron paramagnetic resonance studies of some copper (II) complexes with organophosphorus chelates. Joesten MD, et al.
[J. Am. Chem. Soc. 93(5) , 1138-1140, (1971)]
Extraction of europium and americium into nitrobenzene by using synergistic mixture of hydrogen dicarbollylcobaltate and tetraisopropyl methylene diphosphonate. Makrlík E, et al.
[J. Radioanal. Nucl. Chem. 283(3) , 727-733, (2010)]
Synthesis of novel bisphosphonate polyamine conjugates and their affinity to hydroxyapatite. Sankala E, et al.
[ARKIVOC 4 , 233-241, (2012)]
Synthesis of Tetraisopropyl Methyenediphosphonate. Jian-ming XU.
[Jing Xi Hua Gong Zhong Jian Ti 4 , 007, (2002)]